mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection.
Xu S, Yang K, Li R, Zhang L. · 2020
Read mRNA Vaccine Era-Mechanisms, Drug Platform and Clinical Prospection. by Xu S, Yang K, Li R, Zhang L. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7554980.txt.
Introduction
Xu, Yang, Li and Zhang review the mRNA vaccine platform and its prospects. mRNA drugs have shown promise in immune therapy. Vaccines of this type are now common in trials.
Advantages include high efficacy and mild side effects. Production costs can also be relatively low. Past barriers included weak delivery into cells. Translation of the mRNA message was also limited. New technology has eased both problems. Immune response strength can now be tuned. The review covers uses in infection and cancer. It also looks at bacterial targets such as tuberculosis. Storage and safety questions for future work are discussed.
Catalog record
| CREATOR | Xu S, Yang K, Li R, Zhang L. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 117 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |